The current PE ratio for Collegium Pharmaceutical stock as of Apr 26, 2024 is 25.47. This is calculated based on the current EPS of $1.43 and the stock price of $36.42 per share.
The average historical PE ratio of Collegium Pharmaceutical for the last four years is 26.0. The current PE ratio of 25.47 is 2% below the historical average. Over the past four years, COLL's PE ratio was at its highest in the Sep 2023 quarter at 85.96, when the stock price was $22.35 and the EPS was $0.26. The lowest value was in the Sep 2021 quarter, when it reached 6.71 with a price of $19.74 and an EPS of $2.94.
Maximum annual decrease: -64.52% in 2021
Year | PE ratio | Change |
---|---|---|
2023 | 21.52 | N/A |
2022 | N/A | N/A |
2021 | 9.11 | -64.52% |
2020 | 25.68 | N/A |
2019 | N/A | N/A |
2018 | N/A | N/A |
2017 | N/A | N/A |
2016 | N/A | N/A |
2015 | N/A | N/A |
2014 | N/A | N/A |
Currently, COLL's PE ratio is above the 3-year historical average, but it is below the 5-year average.
COLL's PE ratio is lower than its peer stock SUPN, but it is greater than UTHR's.
Stock name | PE ratio | Market cap |
---|---|---|
UTHR UNITED THERAPEUTICS Corp | 11.11 | $11B |
COLL Collegium Pharmaceutical Inc | 25.47 | $1.16B |
SUPN Supernus Pharmaceuticals Inc | 1,503.5 | $1.65B |
LPCN Lipocine Inc | N/A | $25.57M |
COLL stock has a price to earnings ratio of 25.47 as of Apr 26, 2024.
The average PE ratio for COLL stock over the past 3 years is 24.65.
The average PE ratio for COLL stock over the past 5 years is 26.0.
In the last four years, the Sep 2023 quarter recorded the highest quarterly PE ratio at 85.96.
The current price to earnings ratio of COLL is 2% lower than the 4-year historical average.
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Apr 26, 2024), Collegium Pharmaceutical's stock price is $36.42. The earnings per share for the trailing twelve months (TTM) ending Dec 2023 is $1.43. Therefore, Collegium Pharmaceutical's P/E ratio for today is 25.47. PE RATIO(25.47) = STOCK PRICE($36.42) / TTM EPS($1.43)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.